Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression
Authors:
- Michael J. DetkeMDMichael J. Detke
- Yili LuYLYili Lu
- David J. GoldsteinDGDavid J. Goldstein
- Robert K. McNamaraRMRobert K. McNamara
- Mark A. DemitrackMDMark A. Demitrack
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 36 (6) , 383-390
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Duloxetine in the Treatment of DepressionJournal of Clinical Psychopharmacology, 2004
- Duloxetine in the Treatment of Major Depressive DisorderThe Journal of Clinical Psychiatry, 2002
- Administration of antidepressantsJournal of Affective Disorders, 2001
- Type I Error Rates from Mixed Effects Model Repeated Measures Versus Fixed Effects Anova with Missing Values Imputed Via Last Observation Carried ForwardDrug Information Journal, 2001
- An International Study of the Relation between Somatic Symptoms and DepressionNew England Journal of Medicine, 1999
- Effective management of depression todayInternational Clinical Psychopharmacology, 1996
- Symptoms in the community. Prevalence, classification, and psychiatric comorbidityArchives of internal medicine (1960), 1993
- The QLDS: A scale for the measurement of quality of life in depressionHealth Policy, 1992
- Serotonin and NociceptionAnnals of the New York Academy of Sciences, 1990
- Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin CircuitryAnnual Review of Neuroscience, 1984